ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,995, issued on Nov. 4, was assigned to NEURACLE SCIENCE Co. LTD. (Seoul, South Korea).
"Use of anti-FAM19A5 antibodies" was invented by Bongcheol Kim (Seongnam-si, South Korea), Dong Sik Kim (Seoul, South Korea) and Soon-Gu Kwon (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat a retinopathy (e.g., diabetic retinopathy) and/or maculopathy (e.g., age-related macular degeneration) in a subject in need thereof."
The patent was filed on Oct. 15, 2019, under Application ...